BAUS 2024: Urology and Oncology in Partnership

Bayer Oncology collaborated with the British Association of Urological Surgeons (BAUS) in their ‘Innovations in Urology’ series to explore multidisciplinary team (MDT) collaboration between Oncology and Urology, chaired by leading Urologist, Mr Bill Cross. 

In part 1/3, Dr. Craig Jones and Mr. Omar El-Taji shared insights on the prescribing model implemented at The Christie NHS Foundation Trust and its significant impacts, including: 

• Reducing demand on consultant capacity 
• Optimising the identification and treatment of prostate cancer patients 

This symposium was organised and funded by Bayer plc.

NUBEQA Prescribing Information